Literature DB >> 24779031

Computational delineation of tyrosyl-substrate recognition and catalytic landscapes by the epidermal growth factor receptor tyrosine kinase domain.

Yingting Liu1, Ravi Radhakrishnan.   

Abstract

The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase (RTK), which catalyzes protein phosphorylation reactions by transferring the γ-phosphoryl group from an ATP molecule to the hydroxyl group of tyrosine residues in protein substrates. EGFR is an important drug target in the treatment of cancers and a better understanding of the receptor function is critical to discern cancer mechanisms. We employ a suite of molecular simulation methods to explore the mechanism of substrate recognition and to delineate the catalytic landscape of the phosphoryl transfer reaction. Based on our results, we propose that a highly conserved region corresponding to Val852-Pro853-Ile854-Lys855-Trp856 in the EGFR tyrosine kinase domain (TKD) is essential for substrate binding. We also provide a possible explanation for the established experimental observation that protein tyrosine kinases (including EGFR) select substrates with a glutamic acid at the P - 1 position and a large hydrophobic amino acid at the P + 1 position. Furthermore, our mixed quantum mechanics/molecular mechanics (QM/MM) simulations show that the EGFR protein kinase favors the dissociative mechanism, although an alternative channel through the formation of an associative transition state is also possible. Our simulations establish some key molecular rules in the operation for substrate-recognition and for phosphoryl transfer in the EGFR TKD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24779031      PMCID: PMC4074314          DOI: 10.1039/c3mb70620f

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  82 in total

1.  Structural basis and prediction of substrate specificity in protein serine/threonine kinases.

Authors:  Ross I Brinkworth; Robert A Breinl; Bostjan Kobe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

2.  Comparison of the biochemical and kinetic properties of the type 1 receptor tyrosine kinase intracellular domains. Demonstration of differential sensitivity to kinase inhibitors.

Authors:  Perry S Brignola; Karen Lackey; Sue H Kadwell; Christine Hoffman; Earnest Horne; H Luke Carter; J Darren Stuart; Kevin Blackburn; Mary B Moyer; Krystal J Alligood; Wilson B Knight; Edgar R Wood
Journal:  J Biol Chem       Date:  2001-11-05       Impact factor: 5.157

3.  Molecular modeling of ErbB4/HER4 kinase in the context of the HER4 signaling network helps rationalize the effects of clinically identified HER4 somatic mutations on the cell phenotype.

Authors:  Shannon E Telesco; Rajanikanth Vadigepalli; Ravi Radhakrishnan
Journal:  Biotechnol J       Date:  2013-12-04       Impact factor: 4.677

Review 4.  The EGF receptor family as targets for cancer therapy.

Authors:  J Mendelsohn; J Baselga
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

5.  EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.

Authors:  Ying-Xin Fan; Lily Wong; Gibbes R Johnson
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

6.  Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs.

Authors:  Janine Mok; Philip M Kim; Hugo Y K Lam; Stacy Piccirillo; Xiuqiong Zhou; Grace R Jeschke; Douglas L Sheridan; Sirlester A Parker; Ved Desai; Miri Jwa; Elisabetta Cameroni; Hengyao Niu; Matthew Good; Attila Remenyi; Jia-Lin Nianhan Ma; Yi-Jun Sheu; Holly E Sassi; Richelle Sopko; Clarence S M Chan; Claudio De Virgilio; Nancy M Hollingsworth; Wendell A Lim; David F Stern; Bruce Stillman; Brenda J Andrews; Mark B Gerstein; Michael Snyder; Benjamin E Turk
Journal:  Sci Signal       Date:  2010-02-16       Impact factor: 8.192

7.  Validation and use of the MM-PBSA approach for drug discovery.

Authors:  Bernd Kuhn; Paul Gerber; Tanja Schulz-Gasch; Martin Stahl
Journal:  J Med Chem       Date:  2005-06-16       Impact factor: 7.446

8.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

Authors:  B A Schulman; D L Lindstrom; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Synthetic peptide substrates for the membrane tyrosine protein kinase stimulated by epidermal growth factor.

Authors:  C House; G S Baldwin; B E Kemp
Journal:  Eur J Biochem       Date:  1984-04-16

10.  Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation.

Authors:  Rintaro Noro; Akihiko Gemma; Seiji Kosaihira; Yutaka Kokubo; Mingwei Chen; Masahiro Seike; Kiyoko Kataoka; Kuniko Matsuda; Tetsuya Okano; Yuji Minegishi; Akinobu Yoshimura; Shoji Kudoh
Journal:  BMC Cancer       Date:  2006-12-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.